These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7859596)

  • 1. Hyperproinsulinemia in Japan.
    Kanazawa Y; Kuzuya N; Takeuchi Y; Kubo F; Yamamoto W; Noda M
    Diabetes Res Clin Pract; 1994 Oct; 24 Suppl():S143-4. PubMed ID: 7859596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two unrelated patients with familial hyperproinsulinemia due to a mutation substituting histidine for arginine at position 65 in the proinsulin molecule: identification of the mutation by direct sequencing of genomic deoxyribonucleic acid amplified by polymerase chain reaction.
    Barbetti F; Raben N; Kadowaki T; Cama A; Accili D; Gabbay KH; Merenich JA; Taylor SI; Roth J
    J Clin Endocrinol Metab; 1990 Jul; 71(1):164-9. PubMed ID: 2196279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posttranslational cleavage of proinsulin is blocked by a point mutation in familial hyperproinsulinemia.
    Shibasaki Y; Kawakami T; Kanazawa Y; Akanuma Y; Takaku F
    J Clin Invest; 1985 Jul; 76(1):378-80. PubMed ID: 4019786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial hyperproinsulinemia. Two cohorts secreting indistinguishable type II intermediates of proinsulin conversion.
    Robbins DC; Shoelson SE; Rubenstein AH; Tager HS
    J Clin Invest; 1984 Mar; 73(3):714-9. PubMed ID: 6368587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial hyperproinsulinemia associated with NIDDM. A case study.
    Oohashi H; Ohgawara H; Nanjo K; Tasaka Y; Cao QP; Chan SJ; Rubenstein AH; Steiner DF; Omori Y
    Diabetes Care; 1993 Oct; 16(10):1340-6. PubMed ID: 8269791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel point mutation in the human insulin gene giving rise to hyperproinsulinemia (proinsulin Kyoto).
    Yano H; Kitano N; Morimoto M; Polonsky KS; Imura H; Seino Y
    J Clin Invest; 1992 Jun; 89(6):1902-7. PubMed ID: 1601997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial hyperproinsulinemia due to a proposed defect in conversion of proinsulin to insulin.
    Gruppuso PA; Gorden P; Kahn CR; Cornblath M; Zeller WP; Schwartz R
    N Engl J Med; 1984 Sep; 311(10):629-34. PubMed ID: 6382002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Etiology and molecular biology of hyperproinsulinemia].
    Nakashima N; Umeda F
    Nihon Rinsho; 1994 Oct; 52(10):2556-61. PubMed ID: 7983777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mutation in the B chain coding region is associated with impaired proinsulin conversion in a family with hyperproinsulinemia.
    Chan SJ; Seino S; Gruppuso PA; Schwartz R; Steiner DF
    Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2194-7. PubMed ID: 3470784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Insulinopathy].
    Haruta T; Kobayashi M
    Nihon Rinsho; 1998 Jan; 56 Suppl 3():573-8. PubMed ID: 9513480
    [No Abstract]   [Full Text] [Related]  

  • 11. Relative hyperproinsulinemia of NIDDM persists despite the reduction of hyperglycemia with insulin or sulfonylurea therapy.
    Rachman J; Levy JC; Barrow BA; Manley SE; Turner RC
    Diabetes; 1997 Oct; 46(10):1557-62. PubMed ID: 9313749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperproinsulinemia in a family with a proposed defect in conversion is linked to the insulin gene.
    Elbein SC; Gruppuso P; Schwartz R; Skolnick M; Permutt MA
    Diabetes; 1985 Aug; 34(8):821-4. PubMed ID: 2991050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial hyperproinsulinaemia due to a mutation substituting histidine for arginine at position 65 in proinsulin: identification of the mutation by restriction enzyme mapping.
    Collinet M; Berthelon M; Bénit P; Laborde K; Desbuquois B; Munnich A; Robert JJ
    Eur J Pediatr; 1998 Jun; 157(6):456-60. PubMed ID: 9667398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low levels of sex hormone-binding globulin and hyperproinsulinemia as markers of increased pancreatic beta-cell demand in men.
    Reis AF; Miranda WL; Chacra AR
    Braz J Med Biol Res; 1998 Dec; 31(12):1545-51. PubMed ID: 9951550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sagittal abdominal diameter is a strong anthropometric marker of insulin resistance and hyperproinsulinemia in obese men.
    Risérus U; Arnlöv J; Brismar K; Zethelius B; Berglund L; Vessby B
    Diabetes Care; 2004 Aug; 27(8):2041-6. PubMed ID: 15277437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal insulinemia.
    Nanjo K; Kondo M; Sanke T; Nishi M
    Diabetes Res Clin Pract; 1994 Oct; 24 Suppl():S135-41. PubMed ID: 7859595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new case of familial hyperproinsulinemia.
    Hashimoto T; Aso N; Umeda F; Yamashita T; Ishii H; Noda K; Motomatsu T; Nawata H
    Endocrinol Jpn; 1989 Aug; 36(4):545-52. PubMed ID: 2684621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial hyperproinsulinemia: partial characterization of circulating proinsulin-like material.
    Gabbay KH; Bergenstal RM; Wolff J; Mako ME; Rubenstein AH
    Proc Natl Acad Sci U S A; 1979 Jun; 76(6):2881-5. PubMed ID: 288074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Abnormal insulinemia].
    Nanjo K
    Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):890-5. PubMed ID: 3078053
    [No Abstract]   [Full Text] [Related]  

  • 20. Point mutation in a family with hyperproinsulinemia detected by single stranded conformational polymorphism.
    Nakashima N; Sakamoto N; Umeda F; Hashimoto T; Hisatomi A; Umemura T; Aso N; Sakaki Y; Nawata H
    J Clin Endocrinol Metab; 1993 Mar; 76(3):633-6. PubMed ID: 8445019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.